カテゴリー： 世界, 医療/バイオ, LP Information

世界のウシロタウイルスワクチン市場予測 2023年-2029年

【英語タイトル】Global Bovine Rotavirus Vaccine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC06074）・商品コード：LP23DC06074
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のウシロタウイルスワクチン市場」は、過去の販売実績から2022年の世界のウシロタウイルスワクチンの総販売量を検討し、2023年から2029年の予測されるウシロタウイルスワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウシロタウイルスワクチンの市場規模を掲載し、XXX百万米ドル規模の世界のウシロタウイルスワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界のウシロタウイルスワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウシロタウイルスワクチン市場における各社の独自のポジションをより深く理解するために、ウシロタウイルスワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウシロタウイルスワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウシロタウイルスワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ウシロタウイルスワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウシロタウイルスワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウシロタウイルスワクチンの世界主要メーカーとしては、Zoetis、 MSD Animal Health、 GSK、 Boehringer-Ingelheim、 Serum Institute of India、 Merck Animal Health、 Elanco Animal Health、 Pharmgal Bio、 Creative Biolabs、 Lanzhou Institute of Biological Products、 Weike Biotechnologyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウシロタウイルスワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではウシロタウイルスワクチン市場をセグメンテーションし、種類別 (不活化ワクチン、不活化ワクチン)、用途別 (子牛、成牛)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：不活化ワクチン、不活化ワクチン

・用途別区分：子牛、成牛

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のウシロタウイルスワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見たウシロタウイルスワクチン市場成長の要因は何か？
・ウシロタウイルスワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・ウシロタウイルスワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ウシロタウイルスワクチンの年間販売量2018-2029、地域別現状・将来分析
・ウシロタウイルスワクチンの種類別セグメント：不活化ワクチン、不活化ワクチン
・ウシロタウイルスワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ウシロタウイルスワクチンの用途別セグメント：子牛、成牛
・ウシロタウイルスワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウシロタウイルスワクチン市場
・企業別のグローバルウシロタウイルスワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別のウシロタウイルスワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別のウシロタウイルスワクチン販売価格
・主要企業のウシロタウイルスワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウシロタウイルスワクチンの地域別レビュー
・地域別のウシロタウイルスワクチン市場規模2018-2023：年間販売量、売上
・主要国別のウシロタウイルスワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカのウシロタウイルスワクチン販売の成長
・アジア太平洋のウシロタウイルスワクチン販売の成長
・ヨーロッパのウシロタウイルスワクチン販売の成長
・中東・アフリカのウシロタウイルスワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別のウシロタウイルスワクチン販売量、売上（2018-2023）
・南北アメリカのウシロタウイルスワクチンの種類別販売量
・南北アメリカのウシロタウイルスワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウシロタウイルスワクチン販売量、売上（2018-2023）
・アジア太平洋のウシロタウイルスワクチンの種類別販売量
・アジア太平洋のウシロタウイルスワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウシロタウイルスワクチン販売量、売上（2018-2023）
・ヨーロッパのウシロタウイルスワクチンの種類別販売量
・ヨーロッパのウシロタウイルスワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウシロタウイルスワクチン販売量、売上（2018-2023）
・中東・アフリカのウシロタウイルスワクチンの種類別販売量
・中東・アフリカのウシロタウイルスワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウシロタウイルスワクチンの製造コスト構造分析
・ウシロタウイルスワクチンの製造プロセス分析
・ウシロタウイルスワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ウシロタウイルスワクチンの主要なグローバル販売業者
・ウシロタウイルスワクチンの主要なグローバル顧客

地域別のウシロタウイルスワクチン市場予測レビュー
・地域別のウシロタウイルスワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウシロタウイルスワクチンの種類別市場規模予測
・ウシロタウイルスワクチンの用途別市場規模予測

主要企業分析
Zoetis、 MSD Animal Health、 GSK、 Boehringer-Ingelheim、 Serum Institute of India、 Merck Animal Health、 Elanco Animal Health、 Pharmgal Bio、 Creative Biolabs、 Lanzhou Institute of Biological Products、 Weike Biotechnology
・企業情報
・ウシロタウイルスワクチン製品
・ウシロタウイルスワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Bovine Rotavirus Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bovine Rotavirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bovine Rotavirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bovine Rotavirus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bovine Rotavirus Vaccine players cover Zoetis, MSD Animal Health, GSK, Boehringer-Ingelheim, Serum Institute of India, Merck Animal Health, Elanco Animal Health, Pharmgal Bio and Creative Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Bovine rotavirus is one of the main pathogens that cause viral diarrhea in calves. It has the characteristics of complex genotype, wide spread, high fatality rate, and interspecies transmission. Bovine rotavirus vaccine can effectively reduce viral diarrhea in calves.
LPI (LP Information)’ newest research report, the “Bovine Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Bovine Rotavirus Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Bovine Rotavirus Vaccine sales for 2023 through 2029. With Bovine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Bovine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bovine Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Rotavirus Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Attenuated Vaccine
Inactivated Vaccine
Segmentation by application
Calf
Adult Cow
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Zoetis
MSD Animal Health
GSK
Boehringer-Ingelheim
Serum Institute of India
Merck Animal Health
Elanco Animal Health
Pharmgal Bio
Creative Biolabs
Lanzhou Institute of Biological Products
Weike Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bovine Rotavirus Vaccine market?
What factors are driving Bovine Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bovine Rotavirus Vaccine market opportunities vary by end market size?
How does Bovine Rotavirus Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bovine Rotavirus Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bovine Rotavirus Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bovine Rotavirus Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Bovine Rotavirus Vaccine Segment by Type
2.2.1 Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.3 Bovine Rotavirus Vaccine Sales by Type
2.3.1 Global Bovine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bovine Rotavirus Vaccine Sale Price by Type (2018-2023)
2.4 Bovine Rotavirus Vaccine Segment by Application
2.4.1 Calf
2.4.2 Adult Cow
2.5 Bovine Rotavirus Vaccine Sales by Application
2.5.1 Global Bovine Rotavirus Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bovine Rotavirus Vaccine Sale Price by Application (2018-2023)
3 Global Bovine Rotavirus Vaccine by Company
3.1 Global Bovine Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Bovine Rotavirus Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Bovine Rotavirus Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Bovine Rotavirus Vaccine Revenue by Company (2018-2023)
3.2.2 Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Bovine Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bovine Rotavirus Vaccine Product Location Distribution
3.4.2 Players Bovine Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bovine Rotavirus Vaccine by Geographic Region
4.1 World Historic Bovine Rotavirus Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bovine Rotavirus Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bovine Rotavirus Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Bovine Rotavirus Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bovine Rotavirus Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bovine Rotavirus Vaccine Sales Growth
4.4 APAC Bovine Rotavirus Vaccine Sales Growth
4.5 Europe Bovine Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Bovine Rotavirus Vaccine Sales Growth
5 Americas
5.1 Americas Bovine Rotavirus Vaccine Sales by Country
5.1.1 Americas Bovine Rotavirus Vaccine Sales by Country (2018-2023)
5.1.2 Americas Bovine Rotavirus Vaccine Revenue by Country (2018-2023)
5.2 Americas Bovine Rotavirus Vaccine Sales by Type
5.3 Americas Bovine Rotavirus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bovine Rotavirus Vaccine Sales by Region
6.1.1 APAC Bovine Rotavirus Vaccine Sales by Region (2018-2023)
6.1.2 APAC Bovine Rotavirus Vaccine Revenue by Region (2018-2023)
6.2 APAC Bovine Rotavirus Vaccine Sales by Type
6.3 APAC Bovine Rotavirus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bovine Rotavirus Vaccine by Country
7.1.1 Europe Bovine Rotavirus Vaccine Sales by Country (2018-2023)
7.1.2 Europe Bovine Rotavirus Vaccine Revenue by Country (2018-2023)
7.2 Europe Bovine Rotavirus Vaccine Sales by Type
7.3 Europe Bovine Rotavirus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bovine Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Bovine Rotavirus Vaccine Sales by Type
8.3 Middle East & Africa Bovine Rotavirus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Bovine Rotavirus Vaccine
10.4 Industry Chain Structure of Bovine Rotavirus Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bovine Rotavirus Vaccine Distributors
11.3 Bovine Rotavirus Vaccine Customer
12 World Forecast Review for Bovine Rotavirus Vaccine by Geographic Region
12.1 Global Bovine Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Bovine Rotavirus Vaccine Forecast by Region (2024-2029)
12.1.2 Global Bovine Rotavirus Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bovine Rotavirus Vaccine Forecast by Type
12.7 Global Bovine Rotavirus Vaccine Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 MSD Animal Health
13.2.1 MSD Animal Health Company Information
13.2.2 MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 MSD Animal Health Main Business Overview
13.2.5 MSD Animal Health Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Boehringer-Ingelheim
13.4.1 Boehringer-Ingelheim Company Information
13.4.2 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boehringer-Ingelheim Main Business Overview
13.4.5 Boehringer-Ingelheim Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Merck Animal Health
13.6.1 Merck Animal Health Company Information
13.6.2 Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck Animal Health Main Business Overview
13.6.5 Merck Animal Health Latest Developments
13.7 Elanco Animal Health
13.7.1 Elanco Animal Health Company Information
13.7.2 Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.7.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Elanco Animal Health Main Business Overview
13.7.5 Elanco Animal Health Latest Developments
13.8 Pharmgal Bio
13.8.1 Pharmgal Bio Company Information
13.8.2 Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pharmgal Bio Main Business Overview
13.8.5 Pharmgal Bio Latest Developments
13.9 Creative Biolabs
13.9.1 Creative Biolabs Company Information
13.9.2 Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Creative Biolabs Main Business Overview
13.9.5 Creative Biolabs Latest Developments
13.10 Lanzhou Institute of Biological Products
13.10.1 Lanzhou Institute of Biological Products Company Information
13.10.2 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Lanzhou Institute of Biological Products Main Business Overview
13.10.5 Lanzhou Institute of Biological Products Latest Developments
13.11 Weike Biotechnology
13.11.1 Weike Biotechnology Company Information
13.11.2 Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications
13.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Weike Biotechnology Main Business Overview
13.11.5 Weike Biotechnology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bovine Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bovine Rotavirus Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Bovine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 6. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Bovine Rotavirus Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Bovine Rotavirus Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global Bovine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 11. Global Bovine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Bovine Rotavirus Vaccine Revenue by Application (2018-2023)
Table 13. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Bovine Rotavirus Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global Bovine Rotavirus Vaccine Sales by Company (2018-2023) & (K Doses)
Table 16. Global Bovine Rotavirus Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Bovine Rotavirus Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Bovine Rotavirus Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Bovine Rotavirus Vaccine Products Offered
Table 22. Bovine Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bovine Rotavirus Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Bovine Rotavirus Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bovine Rotavirus Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bovine Rotavirus Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bovine Rotavirus Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Bovine Rotavirus Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bovine Rotavirus Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bovine Rotavirus Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bovine Rotavirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Bovine Rotavirus Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Bovine Rotavirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bovine Rotavirus Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Bovine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Bovine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Bovine Rotavirus Vaccine Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Bovine Rotavirus Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Bovine Rotavirus Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bovine Rotavirus Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Bovine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Bovine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Bovine Rotavirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Bovine Rotavirus Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Bovine Rotavirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bovine Rotavirus Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Bovine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Bovine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bovine Rotavirus Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bovine Rotavirus Vaccine Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Bovine Rotavirus Vaccine Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Bovine Rotavirus Vaccine
Table 58. Key Market Challenges & Risks of Bovine Rotavirus Vaccine
Table 59. Key Industry Trends of Bovine Rotavirus Vaccine
Table 60. Bovine Rotavirus Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bovine Rotavirus Vaccine Distributors List
Table 63. Bovine Rotavirus Vaccine Customer List
Table 64. Global Bovine Rotavirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Bovine Rotavirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bovine Rotavirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Bovine Rotavirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bovine Rotavirus Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Bovine Rotavirus Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bovine Rotavirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Bovine Rotavirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bovine Rotavirus Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Bovine Rotavirus Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bovine Rotavirus Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Bovine Rotavirus Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bovine Rotavirus Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Bovine Rotavirus Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 80. Zoetis Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. MSD Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 85. MSD Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. MSD Animal Health Main Business
Table 87. MSD Animal Health Latest Developments
Table 88. GSK Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 90. GSK Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Boehringer-Ingelheim Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 95. Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 96. Boehringer-Ingelheim Main Business
Table 97. Boehringer-Ingelheim Latest Developments
Table 98. Serum Institute of India Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 100. Serum Institute of India Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments
Table 103. Merck Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 105. Merck Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 106. Merck Animal Health Main Business
Table 107. Merck Animal Health Latest Developments
Table 108. Elanco Animal Health Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 110. Elanco Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 111. Elanco Animal Health Main Business
Table 112. Elanco Animal Health Latest Developments
Table 113. Pharmgal Bio Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 115. Pharmgal Bio Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 116. Pharmgal Bio Main Business
Table 117. Pharmgal Bio Latest Developments
Table 118. Creative Biolabs Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 120. Creative Biolabs Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 121. Creative Biolabs Main Business
Table 122. Creative Biolabs Latest Developments
Table 123. Lanzhou Institute of Biological Products Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 125. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 126. Lanzhou Institute of Biological Products Main Business
Table 127. Lanzhou Institute of Biological Products Latest Developments
Table 128. Weike Biotechnology Basic Information, Bovine Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications
Table 130. Weike Biotechnology Bovine Rotavirus Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 131. Weike Biotechnology Main Business
Table 132. Weike Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Bovine Rotavirus Vaccine
Figure 2. Bovine Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bovine Rotavirus Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Bovine Rotavirus Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bovine Rotavirus Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Attenuated Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Global Bovine Rotavirus Vaccine Sales Market Share by Type in 2022
Figure 12. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Bovine Rotavirus Vaccine Consumed in Calf
Figure 14. Global Bovine Rotavirus Vaccine Market: Calf (2018-2023) & (K Doses)
Figure 15. Bovine Rotavirus Vaccine Consumed in Adult Cow
Figure 16. Global Bovine Rotavirus Vaccine Market: Adult Cow (2018-2023) & (K Doses)
Figure 17. Global Bovine Rotavirus Vaccine Sales Market Share by Application (2022)
Figure 18. Global Bovine Rotavirus Vaccine Revenue Market Share by Application in 2022
Figure 19. Bovine Rotavirus Vaccine Sales Market by Company in 2022 (K Doses)
Figure 20. Global Bovine Rotavirus Vaccine Sales Market Share by Company in 2022
Figure 21. Bovine Rotavirus Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Bovine Rotavirus Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Bovine Rotavirus Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Bovine Rotavirus Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Bovine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 26. Americas Bovine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Bovine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 28. APAC Bovine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Bovine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 30. Europe Bovine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Bovine Rotavirus Vaccine Sales 2018-2023 (K Doses)
Figure 32. Middle East & Africa Bovine Rotavirus Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Bovine Rotavirus Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Bovine Rotavirus Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Bovine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Bovine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Bovine Rotavirus Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Bovine Rotavirus Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Bovine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Bovine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Bovine Rotavirus Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Bovine Rotavirus Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Bovine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Bovine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Bovine Rotavirus Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Bovine Rotavirus Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Bovine Rotavirus Vaccine
Figure 72. Industry Chain Structure of Bovine Rotavirus Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Bovine Rotavirus Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Bovine Rotavirus Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Bovine Rotavirus Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Bovine Rotavirus Vaccine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のウシロタウイルスワクチン市場予測 2023年-2029年] (コード：LP23DC06074)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウシロタウイルスワクチン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の動物インフルエンザワクチン市場予測 2023年-2029年
  • 世界の豚連鎖球菌ワクチン市場予測 2023年-2029年
  • 世界の犬用ボルデテラワクチン市場予測 2023年-2029年
  • 世界の経口ボルデテラワクチン市場予測 2023年-2029年
  • 世界のペット用狂犬病ウイルスワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆